What this assignment does
The assignment reviews opioid analgesics across four levels — receptor and signalling, sites of action in the nervous system, pharmacokinetics of representative agents, and the adaptive phenomena of tolerance, dependence and addiction — then closes on current attempts to design safer opioids. What holds it together is a thesis stated on the first page: the pharmacology of this class is instructive precisely because the same μ-receptor population that produces profound analgesia also produces respiratory depression, tolerance and reward.
That framing decides the structure. The receptor section is written to establish the convergence; the kinetics section is written to show how three agents with the same target behave completely differently in a patient; the tolerance section explains the adaptation at the level of receptor desensitisation, internalisation and compensatory cyclic-AMP signalling; and the final section on biased agonism is presented as the attempt to break the convergence the essay has spent 1,500 words establishing.
The contrasts are doing analytic work rather than filling space. Morphine against fentanyl is a lesson in lipophilicity and onset. Codeine is introduced as the prodrug case that makes CYP2D6 polymorphism matter clinically. Buprenorphine appears twice — once as a ceiling on respiratory depression, once as a drug that can precipitate withdrawal — and both appearances follow from the same property, high affinity with sub-maximal efficacy.
How it is built
The full section list, in order. Read it before you read the extracts: a large part of what makes this document work is the decision about what goes where, and that is visible in the contents alone.
- Abstract
- 1. Introduction
- 2. Opioid Receptors and Mechanisms of Analgesia — receptor subtypes and signalling; sites of analgesic action; the endogenous opioid system
- 3. Pharmacokinetics of Representative Opioids — absorption and first-pass metabolism; metabolism and active metabolites; distribution and routes of administration
- 4. Adverse Effects
- 5. Tolerance, Dependence and Addiction — tolerance; physical dependence and withdrawal; addiction and reward; pharmacological management of opioid use disorder
- 6. Toward Safer Opioids
- 7. Conclusion
- References
c. 2,020 words, Harvard (author–date) referencing, 12 sources cited.
Annotated extracts
Three passages, quoted from the document, each followed by the reasoning a marker would apply to it and by what a weaker answer tends to do in the same place. The extracts are deliberately short — enough to teach the move, not enough to stand in for the assignment.
Clinically used opioids are further classified by their intrinsic activity at the μ-receptor. Full agonists such as morphine, fentanyl and oxycodone produce maximal receptor activation and have no analgesic ceiling, which also means no ceiling to respiratory depression. Partial agonists such as buprenorphine bind with high affinity but produce a sub-maximal effect, giving a ceiling that limits respiratory depression yet can precipitate withdrawal in dependent patients by displacing full agonists. Mixed agonist–antagonists act on different receptor subtypes with differing effects, while pure antagonists such as naloxone and naltrexone occupy the receptor without activating it and are used to reverse or block opioid effects.
Why this marks well
This is a taxonomy that earns its place. Every category is immediately cashed out as a clinical consequence: no ceiling to analgesia therefore no ceiling to respiratory depression; high affinity plus sub-maximal efficacy therefore both a safety ceiling and a withdrawal risk. The classification is not the answer — it is the premise for the answer.
The buprenorphine sentence is the best single sentence in the extract because it derives two opposing clinical facts from one pharmacological property. Markers reward that specifically: it demonstrates the student can reason forward from a mechanism to a bedside consequence rather than recall the two facts separately.
Precision of vocabulary is doing quiet work too. “Intrinsic activity”, “affinity” and “efficacy” are used as distinct terms throughout, which is the single most common place undergraduate pharmacology answers lose marks without realising it.
What a weaker answer does here
A weaker answer gives the same four categories with one drug example each and no consequence attached, so the reader learns a vocabulary list. It typically then uses “potency”, “efficacy” and “affinity” interchangeably in a later paragraph and undoes the earlier accuracy.
Notably, the pattern of tolerance is uneven: tolerance develops readily to analgesia, euphoria and respiratory depression but minimally to constipation and miosis. This differential tolerance has important clinical implications, since dose escalation to maintain analgesia does not confer protection against the persistent gastrointestinal effects, and the constricted pupil remains a useful clinical sign of opioid effect even in tolerant individuals.
Why this marks well
Two sentences, and the second one is entirely implication. The observation that tolerance is selective is not left as a curiosity: it is immediately converted into one prescribing consequence (escalating the dose will not fix the constipation) and one diagnostic consequence (miosis stays informative in a tolerant patient).
This is the kind of paragraph that moves a mark without adding length. It is 60 words. What it demonstrates is the habit markers are actually looking for in a pharmacology assignment: every mechanistic fact is asked “so what follows for a patient?” before it is allowed to stand.
It also quietly supports the essay's thesis. Uneven tolerance is further evidence that benefit and harm are entangled at the receptor rather than separable by dosing, which is what the final section on biased agonism then tries to attack.
What a weaker answer does here
A weaker answer lists adverse effects — respiratory depression, constipation, nausea, sedation, miosis — correctly and in order, states that tolerance develops to some of them, and stops. The clinically useful part, which is the asymmetry, never becomes an argument.
One influential hypothesis proposed that G-protein signalling mediates analgesia whereas β-arrestin recruitment mediates adverse effects, motivating the development of biased agonists that preferentially activate the G-protein pathway. Oliceridine, a G-protein-biased μ-agonist, emerged from this approach, although subsequent work suggests the separation of desirable and undesirable effects is more complex than a simple pathway dichotomy. … These efforts underline a central pharmacological lesson: because benefit and harm arise from the same receptor, achieving therapeutic selectivity requires exploiting subtle differences in downstream signalling rather than the target itself.
Why this marks well
The honesty in the middle clause is the mark-winning move. Having described an elegant hypothesis and the drug that came out of it, the writer immediately concedes that later work complicated the picture. Undergraduates very often present the biased-agonism story as settled; conceding that it is not, while still crediting what it produced, is what a marker reads as current, critical engagement with a live literature.
The closing sentence then converts a research anecdote into a transferable principle, and that principle is the essay's opening thesis restated with more force than it had on page one. Beginning and ending on the same idea, with 1,800 words of evidence in between, is the structural pattern that most reliably reads as “argued” rather than “covered”.
Note what is not here: no speculation about future drugs, no unsupported optimism. The forward-looking section stays inside what the cited literature supports.
What a weaker answer does here
A weaker answer ends with a paragraph of generic optimism — new research is ongoing, safer opioids may be developed — which adds length and no marks because nothing in it is attributable to a source or connected to the preceding argument.
What makes this a strong answer
Pulling the annotations together. None of these are subject-specific tricks; they are what UK undergraduate marking criteria mean by explanation and critical engagement.
- One thesis — benefit and harm share a receptor — stated early, tested in every section, and restated with more evidence at the end.
- Drug comparisons chosen because they teach a principle (lipophilicity and onset; prodrug and pharmacogenetics; affinity versus efficacy), not because they fill a paragraph.
- Mechanistic claims consistently followed by their clinical consequence inside the same paragraph.
- Terminology kept precise where pharmacology answers usually slip: affinity, efficacy, intrinsic activity and potency are used as different words because they mean different things.
- A live controversy conceded as unresolved rather than tidied into a conclusion.
Request the full document
Request the full document
The extracts above are the teaching material and they stay on this page. The complete 2,020-word document is sent person to person, by a human, after a short conversation about what you are working on — so that we can point you at the right parts of it rather than hand over a file and wish you luck.
Both links below already name this sample (BMS-02), so you do not have to describe it.
WhatsApp · +44 7537 126 976 · Email · mia@globalprojectshelp.com
Mon–Sat, 9–22 GMT. No form, no mailing list, no download gate.
Full documents are never published, hosted or linked on this site.
Using this sample honestly
This is a worked example. It sits in the same place as a worked example in a textbook or a past paper with an examiner’s report attached: read it, take the move, then write your own paragraph without it open in another window.
Submitting any part of this document as your own work would be plagiarism — the same offence as copying from a journal article, and detected the same way. If you draw on it, cite it. If a deadline has got to the point where submitting someone else’s paragraph feels like an option, say so when you message us; that is a problem with a legitimate answer and we would rather work on it than watch it happen.
Our full position, including how to declare mentoring support to your institution, is on the academic integrity policy page.
Where to go next
- More biomedical science samples The other three assignments in this set, each annotated the same way.
- All samples Every annotated model answer in the library, with discipline filters.
- How requesting works What you receive, what you do not, and the conditions attached.
- Academic integrity policy What we do, what we will not do, and how to declare mentoring support.
Model answer written by a Global Projects Help mentor · © Global Projects Help
Published 8 October 2026 · Questions? mia@globalprojectshelp.com